Jiang et al. have reported that miR-16 expression was downregulated in BCs in comparison with the adjacent normal tissues; and miR-16 could inhibit BC cell proliferation by targeting cyclin D1 in TCHu-1 cells [42]. Here, CCND1 is linked to breast cancer.